These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 29357810)

  • 1. Cytochrome P450 1A2 Messenger RNA is a More Reliable Marker than Cytochrome P450 1A2 Activity, Phenacetin O-Deethylation, for Assessment of Induction Potential of Drug-Metabolizing Enzymes Using HepaRG Cells.
    Ogasawara A; Kato N; Torimoto N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2018; 12(1):14-23. PubMed ID: 29357810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
    Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
    J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Screening Criteria Setting on Evaluation of Cytochrome P450 Induction Using HepaRG Cells with Multiplex Branched DNA Technologies in Early Drug Discovery.
    Ogasawara A; Torimoto N; Tsuda N; Aohara F; Ohashi R; Yamada Y; Taniguchi H
    Drug Metab Lett; 2016; 10(3):152-160. PubMed ID: 27550199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human HepaRG Cells can be Cultured in Hanging-drop Plates for Cytochrome P450 Induction and Function Assays.
    Murayama N; Usui T; Slawny N; Chesné C; Yamazaki H
    Drug Metab Lett; 2015; 9(1):3-7. PubMed ID: 25600204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents.
    Uehara S; Uno Y; Suzuki T; Inoue T; Utoh M; Sasaki E; Yamazaki H
    Drug Metab Lett; 2017; 10(4):244-253. PubMed ID: 27842484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient assessment of the utility of immortalized Fa2N-4 cells for cytochrome P450 (CYP) induction studies using multiplex quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and substrate cassette methodologies.
    Kenny JR; Chen L; McGinnity DF; Grime K; Shakesheff KM; Thomson B; Riley R
    Xenobiotica; 2008 Dec; 38(12):1500-17. PubMed ID: 18989830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omeprazole Induces CYP3A4 mRNA Expression but Not CYP3A4 Protein Expression in HepaRG Cells.
    Fujita Y; Miyake T; Shao X; Aoki Y; Hasegawa E; Doi M
    Biol Pharm Bull; 2024; 47(6):1218-1223. PubMed ID: 38925922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cytochrome P450 inductions by anti-epileptic drug oxcarbazepine, 10-hydroxyoxcarbazepine, and carbamazepine using human hepatocytes and HepaRG cells.
    Sugiyama I; Murayama N; Kuroki A; Kota J; Iwano S; Yamazaki H; Hirota T
    Xenobiotica; 2016 Sep; 46(9):765-74. PubMed ID: 26711482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective Suppression of CYP3A4 mRNA and Enzyme Activity by Epidermal Growth Factor in Plated Human Hepatocytes.
    Zhang JG; Wang D; Ho T; Clark RJ; Stresser DM
    Drug Metab Lett; 2017; 11(2):119-127. PubMed ID: 29189189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metamizole is a Moderate Cytochrome P450 Inducer Via the Constitutive Androstane Receptor and a Weak Inhibitor of CYP1A2.
    Bachmann F; Duthaler U; Meyer Zu Schwabedissen HE; Puchkov M; Huwyler J; Haschke M; Krähenbühl S
    Clin Pharmacol Ther; 2021 Jun; 109(6):1505-1516. PubMed ID: 33336382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconvolution of Cytochrome P450 Induction Mechanisms in HepaRG Nuclear Hormone Receptor Knockout Cells.
    Preiss LC; Liu R; Hewitt P; Thompson D; Georgi K; Badolo L; Lauschke VM; Petersson C
    Drug Metab Dispos; 2021 Aug; 49(8):668-678. PubMed ID: 34035124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells.
    Anthérieu S; Chesné C; Li R; Camus S; Lahoz A; Picazo L; Turpeinen M; Tolonen A; Uusitalo J; Guguen-Guillouzo C; Guillouzo A
    Drug Metab Dispos; 2010 Mar; 38(3):516-25. PubMed ID: 20019244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 'all-inclusive' 96-well cytochrome P450 induction method: measuring enzyme activity, mRNA levels, protein levels, and cytotoxicity from one well using cryopreserved human hepatocytes.
    Halladay JS; Wong S; Khojasteh SC; Grepper S
    J Pharmacol Toxicol Methods; 2012; 66(3):270-5. PubMed ID: 22809809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-endpoint evaluation of cytochrome P450 1A2, 2B6 and 3A4 induction response in human hepatocyte cultures after treatment with β-naphthoflavone, phenobarbital and rifampicin.
    Zhang JG; Ho T; Callendrello AL; Crespi CL; Stresser DM
    Drug Metab Lett; 2010 Dec; 4(4):185-94. PubMed ID: 20583967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes.
    Madan A; Graham RA; Carroll KM; Mudra DR; Burton LA; Krueger LA; Downey AD; Czerwinski M; Forster J; Ribadeneira MD; Gan LS; LeCluyse EL; Zech K; Robertson P; Koch P; Antonian L; Wagner G; Yu L; Parkinson A
    Drug Metab Dispos; 2003 Apr; 31(4):421-31. PubMed ID: 12642468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up to the pre-validation of a harmonised protocol for assessment of CYP induction responses in freshly isolated and cryopreserved human hepatocytes with respect to culture format, treatment, positive reference inducers and incubation conditions.
    Abadie-Viollon C; Martin H; Blanchard N; Pekthong D; Bachellier P; Mantion G; Heyd B; Schuler F; Coassolo P; Alexandre E; Richert L
    Toxicol In Vitro; 2010 Feb; 24(1):346-56. PubMed ID: 19497360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans.
    Kanebratt KP; Andersson TB
    Drug Metab Dispos; 2008 Jan; 36(1):137-45. PubMed ID: 17954527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
    Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
    Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics.
    Choi JM; Oh SJ; Lee SY; Im JH; Oh JM; Ryu CS; Kwak HC; Lee JY; Kang KW; Kim SK
    Arch Pharm Res; 2015; 38(5):691-704. PubMed ID: 25336106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.